WHY CHOOSE ONCE-DAILY RELEXXII

Once-daily RELEXXII (methylphenidate hydrochloride extended-release tablets) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients > 6 years of age and adult patients < 65 years.1

Watch How It Works
  • RELEXXII one tablet daily extended-release ADHD medication
    ONE TABLET DAILY

    Once-daily RELEXXII simplifies ADHD treatment with its extended release formulation made possible by Osmodex Drug Delivery Technology.1,2

  • RELEXXII seven strength options for tailored ADHD treatment
    SEVEN STRENGTHS

    RELEXXII provides the power to choose from seven strengths to support individual needs throughout the ADHD treatment journey.

  • RELEXXII 45 mg and 63 mg in-between extended-release strengths
    TWO “IN-BETWEEN” STRENGTHS

    RELEXXII 45 mg and 63 mg provide two "in-between" strengths, specifically designed to optimize to the lowest effective dose for symptom management.

  • RELEXXII dosing in 9 mg increments for dose flexibility
    9 MG INCREMENTS

    RELEXXII provides the option to more gradually increase or decrease the dose in 9 mg increments to better support a tailored treatment approach.

Review Dosing Options
Patients and care partners exploring RELEXXII once-daily ADHD treatment

Patients and Care Partners

Learn why RELEXXII may be right for you.

Learn More
Healthcare practitioners reviewing RELEXXII clinical data and dosing

Practitioners

Learn more about treating your patients with RELEXXII.

Learn More
RELEXXII savings card co-pay assistance for ADHD medication

Pay as little as $0 per month with the RELEXXII® Savings Card*

Start Saving
Locate RELEXXII extended-release tablets near you with Medfinder tool

Locate RELEXXII® at a pharmacy near you with Medfinder

Find Relexxii

References: 1. RELEXXII package insert. Vertical Pharmaceuticals, LLC. 2. Data on file, Osmotica Pharmaceuticals.

*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. Offer effective 04/2024. Alora Pharmaceuticals, LLC reserves the right to rescind, revoke, or amend this offer without notice. For full terms and conditions, click here.

All individuals depicted are models used for illustrative purposes only.

You are entering an area of the site for healthcare providers.

By clicking below, you verify you are a healthcare provider.